Champions Oncology Inc. | Key People and Executives
Ronnie Morris
Chief Executive Officer & Director
Philip Breitfeld
Director, Chief Strategy & Innovation Officer
David Sidransky
Lead Independent Director
Daniel N. Mendelson
Independent Director
Abba David Poliakoff
Independent Director
Scott R. Tobin
Independent Director
Ronnie Morris
Chief Executive Officer & Director
David Barry Miller
CFO & Principal Accounting Officer
Angela M. Davies
Chief Medical Officer
Mark Weinstein
Chief Information Officer
Philip Breitfeld
Director, Chief Strategy & Innovation Officer
Neal Goodwin
Vice President-Research Development
Amy K. Wesa
Director-Immuno Oncology Research
Maria Mancini
Vice President-Pharmacology
David DeOrnellis
Global Director-Laboratory Operations
Jordan Rubinson
Chief Commercial Officer
Susan J. Foreman
Press & Media Contact
David Sidransky
Lead Independent Director
Daniel N. Mendelson
Independent Director
Abba David Poliakoff
Independent Director
Scott R. Tobin
Independent Director
| Address |
One University Plaza
Hackensack New Jersey 07601
United States
|
|
Employees
|
- |
| Website |
http://www.championsoncology.com |
| Updated |
07/08/2019 |
| Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. |
